154 related articles for article (PubMed ID: 8520727)
1. Transgenic and natural mouse models of proteolipid protein (PLP)-related dysmyelination and demyelination.
Griffiths IR; Schneider A; Anderson J; Nave KA
Brain Pathol; 1995 Jul; 5(3):275-81. PubMed ID: 8520727
[TBL] [Abstract][Full Text] [Related]
2. Glial cell degeneration and hypomyelination caused by overexpression of myelin proteolipid protein gene.
Kagawa T; Ikenaka K; Inoue Y; Kuriyama S; Tsujii T; Nakao J; Nakajima K; Aruga J; Okano H; Mikoshiba K
Neuron; 1994 Aug; 13(2):427-42. PubMed ID: 7520255
[TBL] [Abstract][Full Text] [Related]
3. Premature arrest of myelin formation in transgenic mice with increased proteolipid protein gene dosage.
Readhead C; Schneider A; Griffiths I; Nave KA
Neuron; 1994 Mar; 12(3):583-95. PubMed ID: 7512350
[TBL] [Abstract][Full Text] [Related]
4. Current concepts of PLP and its role in the nervous system.
Griffiths I; Klugmann M; Anderson T; Thomson C; Vouyiouklis D; Nave KA
Microsc Res Tech; 1998 Jun; 41(5):344-58. PubMed ID: 9672418
[TBL] [Abstract][Full Text] [Related]
5. PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease.
Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Kirkham D; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
Glia; 2007 Mar; 55(4):341-51. PubMed ID: 17133418
[TBL] [Abstract][Full Text] [Related]
6. The proteolipid protein gene.
Griffiths IR; Montague P; Dickinson P
Neuropathol Appl Neurobiol; 1995 Apr; 21(2):85-96. PubMed ID: 7541901
[TBL] [Abstract][Full Text] [Related]
7. Assembly of CNS myelin in the absence of proteolipid protein.
Klugmann M; Schwab MH; Pühlhofer A; Schneider A; Zimmermann F; Griffiths IR; Nave KA
Neuron; 1997 Jan; 18(1):59-70. PubMed ID: 9010205
[TBL] [Abstract][Full Text] [Related]
8. The early phenotype associated with the jimpy mutation of the proteolipid protein gene.
Thomson CE; Anderson TJ; McCulloch MC; Dickinson P; Vouyiouklis DA; Griffiths IR
J Neurocytol; 1999 Mar; 28(3):207-21. PubMed ID: 10617903
[TBL] [Abstract][Full Text] [Related]
9. PLP/DM20 expression and turnover in a transgenic mouse model of Pelizaeus-Merzbacher disease.
Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Iden DL; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
Glia; 2010 Nov; 58(14):1727-38. PubMed ID: 20629189
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic severity of murine Plp mutants reflects in vivo and in vitro variations in transport of PLP isoproteins.
Thomson CE; Montague P; Jung M; Nave KA; Griffiths IR
Glia; 1997 Aug; 20(4):322-32. PubMed ID: 9262236
[TBL] [Abstract][Full Text] [Related]
11. Late-onset neurodegeneration in mice with increased dosage of the proteolipid protein gene.
Anderson TJ; Schneider A; Barrie JA; Klugmann M; McCulloch MC; Kirkham D; Kyriakides E; Nave KA; Griffiths IR
J Comp Neurol; 1998 May; 394(4):506-19. PubMed ID: 9590558
[TBL] [Abstract][Full Text] [Related]
12. Dominant-negative action of the jimpy mutation in mice complemented with an autosomal transgene for myelin proteolipid protein.
Schneider AM; Griffiths IR; Readhead C; Nave KA
Proc Natl Acad Sci U S A; 1995 May; 92(10):4447-51. PubMed ID: 7538670
[TBL] [Abstract][Full Text] [Related]
13. Uncoupling of hypomyelination and glial cell death by a mutation in the proteolipid protein gene.
Schneider A; Montague P; Griffiths I; Fanarraga M; Kennedy P; Brophy P; Nave KA
Nature; 1992 Aug; 358(6389):758-61. PubMed ID: 1380672
[TBL] [Abstract][Full Text] [Related]
14. Expression of a myelin proteolipid protein (Plp)-lacZ transgene is reduced in both the CNS and PNS of Plp(jp) mice.
Wight PA; Duchala CS; Shick HE; Gudz TI; Macklin WB
Neurochem Res; 2007 Feb; 32(2):343-51. PubMed ID: 17191136
[TBL] [Abstract][Full Text] [Related]
15. Pelizaeus-Merzbacher disease.
Koeppen AH; Robitaille Y
J Neuropathol Exp Neurol; 2002 Sep; 61(9):747-59. PubMed ID: 12230321
[TBL] [Abstract][Full Text] [Related]
16. Processing of PLP in a model of Pelizaeus-Merzbacher disease/SPG2 due to the rumpshaker mutation.
McLaughlin M; Barrie JA; Karim S; Montague P; Edgar JM; Kirkham D; Thomson CE; Griffiths IR
Glia; 2006 May; 53(7):715-22. PubMed ID: 16506223
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of apoptotic markers in jimpy and in Plp overexpressors: evidence for different apoptotic pathways.
Cerghet M; Bessert DA; Nave KA; Skoff RP
J Neurocytol; 2001; 30(9-10):841-55. PubMed ID: 12165674
[TBL] [Abstract][Full Text] [Related]
18. Proteolipid protein is necessary in peripheral as well as central myelin.
Garbern JY; Cambi F; Tang XM; Sima AA; Vallat JM; Bosch EP; Lewis R; Shy M; Sohi J; Kraft G; Chen KL; Joshi I; Leonard DG; Johnson W; Raskind W; Dlouhy SR; Pratt V; Hodes ME; Bird T; Kamholz J
Neuron; 1997 Jul; 19(1):205-18. PubMed ID: 9247276
[TBL] [Abstract][Full Text] [Related]
19. Neural stem cells restore myelin in a demyelinating model of Pelizaeus-Merzbacher disease.
Gruenenfelder FI; McLaughlin M; Griffiths IR; Garbern J; Thomson G; Kuzman P; Barrie JA; McCulloch ML; Penderis J; Stassart R; Nave KA; Edgar JM
Brain; 2020 May; 143(5):1383-1399. PubMed ID: 32419025
[TBL] [Abstract][Full Text] [Related]
20. Perturbed interactions of mutant proteolipid protein/DM20 with cholesterol and lipid rafts in oligodendroglia: implications for dysmyelination in spastic paraplegia.
Krämer-Albers EM; Gehrig-Burger K; Thiele C; Trotter J; Nave KA
J Neurosci; 2006 Nov; 26(45):11743-52. PubMed ID: 17093095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
